Header cover image

Japanese Pharmaceuticals & Biotech Your first investment

Results

9

1 new
Based on available information up to March 12, 2025, Donald Trump’s plans for oil and gas focus on maximizing U.S. production, reducing regulatory barriers, and prioritizing fossil fuels as a cornerstone of his energy policy. Here’s a concise overview of his intentions: Boost Production and Permitting: Trump has pledged to "unleash" American oil and gas by accelerating permitting processes. On his first day in office (January 20, 2025), he signed executive orders declaring a "national energy emergency" to fast-track approvals for energy infrastructure like pipelines, refineries, and power plants. This includes expanding drilling on federal lands and offshore areas, reversing Biden-era restrictions.

9 companies

Chugai Pharmaceutical

Market Cap: JP¥11.3t

Engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally.

New

4519

JP¥6,848.00

7D

-6.5%

1Y

-7.8%

Otsuka Holdings

Market Cap: JP¥5.9t

Engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide.

4578

JP¥11,325.00

7D

3.0%

1Y

61.6%

Astellas Pharma

Market Cap: JP¥4.0t

Engages in the research, development, manufacture, sale, and supply of pharmaceuticals in Japan and internationally.

4503

JP¥2,210.00

7D

2.7%

1Y

48.3%

Shionogi

Market Cap: JP¥2.5t

Engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan and internationally.

4507

JP¥2,894.50

7D

0.6%

1Y

13.6%

Kyowa Kirin

Market Cap: JP¥1.4t

Engages in the research, development, manufacturing, and marketing of pharmaceuticals in Japan, the Americas, Europe, Asia, and internationally.

4151

JP¥2,661.00

7D

0.2%

1Y

3.4%

Ono Pharmaceutical

Market Cap: JP¥1.1t

Produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide.

4528

JP¥2,435.00

7D

0.4%

1Y

49.3%

Santen Pharmaceutical

Market Cap: JP¥634.4b

Engages in the research and development, manufacturing, and marketing of pharmaceuticals and medical devices in Japan, China, Asia, Europe, the Middle East, Africa, and internationally.

4536

JP¥1,972.00

7D

-3.5%

1Y

18.9%

Tsumura

Market Cap: JP¥283.2b

Engages in the production and sale of Kampo extract intermediates and granular Kampo formulations in Japan and internationally.

4540

JP¥3,799.00

7D

-1.3%

1Y

3.8%

Nippon Shinyaku

Market Cap: JP¥274.1b

Manufactures and sells pharmaceuticals and foodstuffs in Japan and internationally.

4516

JP¥4,066.00

7D

0.4%

1Y

27.1%